Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

ANG Lifesciences India Ltd - 540694 - Submission Of Voting Result Along With Scrutinizer'S Report Pursuant To Regulation 44(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015.

 Dear Sir, With reference to our letter dated 03rd June, 2022 enclosing notice of Postal Ballot/ Evoting along with explanatory statement for seeking the approval of Shareholders, we are pleased to inform you that the resolutions as stated in notice have been passed by the members of the Company with requisite majority. In this regard, please find enclosed the following: (1) Voting Results as required under regulation 44(3) of the Securities & Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation. (2) Scrutinizer's Report dated 04-July-2022, pursuant to section 108 and 110 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014. The Voting results along with the Scrutinizer's report will also be available at the website of the Company. We request you to kindly take the same on your record.
04-07-2022

Multibagger pharma stock announces record date for bonus issue

 ANG Lifesciences India Ltd. is a small-cap pharmaceutical company with a market worth of Rs. 184.99 crore.
03-07-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Intimation Of Record Date For The Purpose Of Allotment Of Bonus Equity Shares As Per Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015.

 Pursuant to the provisions of Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in their meeting held on today, has fixed Thursday, 14th July, 2022 as ''Record date'' for the purpose of determining the eligibility of shareholders for the entitlement of issue of Bonus equity shares in proportion of One (1) new equity share for every Four (4) existing equity shares, subject to the shareholders'' approval sought through Postal Ballot/Evoting. Kindly acknowledge receipt of the same.
01-07-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Disclosure Of Related Party Transactions For The Half Year Ended 31St March 2022

 Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of related party transactions on a consolidated basis, for the half year ended 31st March 2022. Kindly acknowledge the receipt of the same.
01-07-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Closure of Trading Window

 Dear Sir/Madam, Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, and the Company''s Code of Conduct for Regulating, Monitoring, and Reporting of trading by insiders and Code of practices and procedures for fair disclosure of unpublished price sensitive information, the trading window for dealing in the securities of the Company shall remain closed for all Designated Persons/Connected Persons/Directors with effect from Friday, July 01, 2022, till the expiry of 48 hours after the announcement/declaration of Unaudited Standalone & Consolidated Financial Results of the Company for the Quarter ended on June 30, 2022. The date of the Board Meeting to consider and approve, inter alia, the Unaudited Standalone Financial Results of the Company for the Quarter ended on June 30, 2022, shall be intimated in due course of time.
30-06-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajesh Gupta
15-06-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015.

 Dear Sir/ Madam, Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby wish to inform you that Mr. Rajesh Gupta, Managing Director of the Company has acquired 1000 shares on today.
13-06-2022

Multibagger stock to consider 1:4 bonus share issue. Details here

 Multibagger stock: ANG Lifesciences India Ltd has informed Indian bourses that its board of directors has recommended issuance of bonus shares in 1:4 ratio
07-06-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to the above captioned subject, we enclose herewith the copies of Newspaper Advertisement published on 05th June, 2022 in connection with the dispatch of Postal Ballot Notice to the Shareholders of the Company on 03rd June, 2022.
05-06-2022
Bigul

ANG Lifesciences India Ltd - 540694 - Revised Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are enclosing herewith the revised certificate issued by Practicing Company Secretary for the year ended 31st March, 2022. Kindly acknowledge the receipt of the same.
05-06-2022
Next Page
Close

Let's Open Free Demat Account